Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing.
Glewis S, Alexander M, Khabib MNH, Brennan A, Lazarakis S, Martin J, Tie J, Lingaratnam S, Michael M. Glewis S, et al. Among authors: brennan a. Br J Cancer. 2022 Jul;127(1):126-136. doi: 10.1038/s41416-022-01779-6. Epub 2022 Mar 19. Br J Cancer. 2022. PMID: 35306539 Free PMC article.
The use of menopausal hormone therapy after cancer.
Brennan A, Hickey M. Brennan A, et al. Best Pract Res Clin Obstet Gynaecol. 2022 May;81:22-30. doi: 10.1016/j.bpobgyn.2021.11.005. Epub 2021 Nov 15. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 34920970 Review.
Managing vasomotor symptoms effectively without hormones.
McCormick CA, Brennan A, Hickey M. McCormick CA, et al. Among authors: brennan a. Climacteric. 2020 Dec;23(6):532-538. doi: 10.1080/13697137.2020.1789093. Epub 2020 Jul 22. Climacteric. 2020. PMID: 32696683 Review.
Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II Trial.
Beattie WS, Wijeysundera DN, Chan MTV, Peyton PJ, Leslie K, Paech MJ, Sessler DI, Wallace S, Myles PS, Galagher W, Farrington C, Ditoro A, Baulch S, Sidiropoulos S, Bulach R, Bryant D, O'Loughlin E, Mitteregger V, Bolsin S, Osborne C, McRae R, Backstrom M, Cotter R, March S, Silbert B, Said S, Halliwell R, Cope J, Fahlbusch D, Crump D, Thompson G, Jefferies A, Reeves M, Buckley N, Tidy T, Schricker T, Lattermann R, Iannuzzi D, Carroll J, Jacka M, Bryden C, Badner N, Tsang MWY, Cheng BCP, Fong ACM, Chu LCY, Koo EGY, Mohd N, Ming LE, Campbell D, McAllister D, Walker S, Olliff S, Kennedy R, Eldawlatly A, Alzahrani T, Chua N, Sneyd R, McMillan H, Parkinson I, Brennan A, Balaji P, Nightingale J, Kunst G, Dickinson M, Subramaniam B, Banner-Godspeed V, Liu J, Kurz A, Hesler B, Fu AY, Egan C, Fiffick AN, Hutcherson MT, Turan A, Naylor A, Obal D, Cooke E; ANZCA Clinical Trials Network for the ENIGMA-II Investigators. Beattie WS, et al. Among authors: brennan a. Anesth Analg. 2018 Nov;127(5):1118-1126. doi: 10.1213/ANE.0000000000003310. Anesth Analg. 2018. PMID: 29533264 Clinical Trial.
Percutaneous coronary intervention outcomes based on American College of Cardiology/American Heart Association coronary lesion classification over 14 years - Melbourne interventional group (MIG) registry.
Nezafati P, Ajani A, Dinh D, Brennan A, Clark D, Reid CM, Hiew C, Freeman M, Stub D, Chandrasekhar J, Sharma A, Oqueli E. Nezafati P, et al. Among authors: brennan a. Cardiovasc Revasc Med. 2024 Jun 11:S1553-8389(24)00540-2. doi: 10.1016/j.carrev.2024.06.010. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38876940
1,267 results